Free Submission Public Relations &
Deutsch English


New Market Report: Cat Allergy - Pipeline Review, H2 2013

Print article Print article
2013-10-05 20:29:06 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Cat Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cat Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cat Allergy. Cat Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated



* A snapshot of the global therapeutic scenario for Cat Allergy.
* A review of the Cat Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Cat Allergy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Cat Allergy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Cat Allergy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: ALK-Abello A/S, Circassia Holdings Ltd., Biomay AG

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Cat Allergy Overview
Therapeutics Development
An Overview of Pipeline Products for Cat Allergy
Cat Allergy Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Cat Allergy Therapeutics - Products under Development by Companies
Companies Involved in Cat Allergy Therapeutics Development
ALK-Abello A/S
Circassia Holdings Ltd.
Biomay AG
Cat Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Cat-SPIRE - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALK Recombinant Cat Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cat Allergen Peptide Carrier Fusion Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cat Allergen Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cat Allergy Therapeutics - Drug Profile Updates
Cat Allergy Therapeutics - Discontinued Products
Cat Allergy Therapeutics - Dormant Products
Cat Allergy - Product Development Milestones
Featured News & Press Releases
Feb 25, 2013: Circassia's ToleroMune Cat Allergy Treatment Maintains Symptom Improvement Two Years After Start Of Short-course Therapy
Oct 04, 2012: Circassia Initiates Pivotal Phase III ToleroMune Trial In Cat Allergen-induced Rhinoconjunctivitis
Sep 27, 2012: Circassia Announces Publication Of ToleroMune Cat Allergy Treatment Clinical Results In Journal of Allergy And Clinical Immunology
Jun 13, 2011: Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction In Allergy Symptoms During 12-Month Follow-up
Feb 01, 2011: Circassia's ToleroMune T-cell Vaccine Achieves Significant Reduction In Allergy Symptoms In Key Phase II Clinical Study
Jan 19, 2010: Circassia Extends Its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite And Cat Allergies
Nov 20, 2009: Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune Cat Allergy Therapy
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

List of Tables
Number of Products Under Development for Cat Allergy, H2 2013
Products under Development for Cat Allergy - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Comparative Analysis by Late Stage Development, H2 2013
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013
Products under Development by Companies, H2 2013
ALK-Abello A/S, H2 2013
Circassia Holdings Ltd., H2 2013
Biomay AG, H2 2013
Assessment by Monotherapy Products, H2 2013
Assessment by Stage and Route of Administration, H2 2013
Assessment by Stage and Molecule Type, H2 2013
Cat Allergy Therapeutics - Drug Profile Updates
Cat Allergy Therapeutics - Discontinued Products
Cat Allergy Therapeutics - Dormant Products

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact